Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. By letter dated July 24, 2026, Nasdaq notified the Company that the Company’s Market Value of Publicly Held Shares (“ MVPHS”) did not maintain the minimum MVPHS of $1 million during the last 30 consecutive business days (June 10, 2026 to July 23, 2026), as required by Nasdaq Listing Rule 5550(a)(5). Consequently, the Company no longer meets the listed securities requirement to maintain minimum MVPHS of $1,000,000 pursuant to Nasdaq Rules 5550(a)(5). The Nasdaq Rules provide a compliance period of 180 calendar days, through January 20, 2027, in which to regain compliance. Under the Nasdaq Rules, if at any time during this 180-day compliance period the MVPHS of the Company’s securities is at least $1,000,000 for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance, and the matter would be closed. However, Nasdaq has the discretion to require the Company to satisfy the MVPHS requirement for a period in excess of ten consecutive business days, but generally no more than twenty consecutive business days, before determining that the company has demonstrated an ability to maintain long term compliance. The Company is reviewing the Nasdaq Deficiency Notice and evaluating the alternatives that may be available to it to regain and thereafter sustain compliance with the MVPHS Requirement and with all other applicable Nasdaq continued listing requirements. As of the date of this Current Report, the Company’s board of directors has not determined which alternative or combination of alternatives, if any, it will pursue. There can be no assurance that the Company will regain compliance with the MVPHS Requirement, or that the Company’s securities will remain listed on Nasdaq. In the event that the Company does not regain compliance during the 180-day compliance period, Nasdaq will provide written notification to the Company that its Common Stock is subject to delisting. At that time, the Company may appeal the relevant delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if the Company does appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would be successful. Item9.01Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description ───────────────────────────────────────────────────────────────────────────────── 104 Cover Page Interactive Data File (formatted as Inline XBRL). SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCWorx Corp. By: /s/ Timothy Hannibal Timothy Hannibal CEO